EUVIMEDEUVIMED entdecken
Crossref

Performance of the Anca Renal and Kidney Risk Scores in Predicting Renal Outcome in A New Zealand Cohort

Saiprasad Ravi iD, Alina Ali, Tze Liang Goh

Nephrology · 2026-04 · 31 (4)

DOI: 10.1111/nep.70207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology, online erschienen am 22.04.2026. Verfasst von Saiprasad Ravi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Renal Service, Auckland City Hospital, Auckland, New Zealand. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Glomerulonephritis. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

There is emerging evidence for the ANCA Renal Risk Score (ARRS) and ANCA Kidney Risk Score (AKRiS) as simple and effective measures to predict risk of end‐stage kidney disease (ESKD) in glomerulonephritis (GN) secondary to ANCA‐associated vasculitis (AAV). We sought to externally validate these scores on an Aotearoa New Zealand (AoNZ) cohort.

Methods

Using a biopsy database, cases of pauci‐immune GN in the three metropolitan Auckland districts between 1 January 2008 and31 December 2018 were retrospectively identified and histopathological data extracted. Hospital electronic records were screened to obtain relevant clinical information. Cox proportional hazards model was used to estimate survival distributions and perform receiver operating characteristic curve analysis.

Results

One hundred twenty‐one patients had sufficient data for risk score calculation. The cohort was predominantly male (60%) and of European ethnicity (71%). Māori and Pacific Peoples comprised 12% of the cohort. The vast majority (82%) of patients received cyclophosphamide induction. Ethnicity was associated with AKRiS score ( p = 0.015) with Pacific Peoples being over‐represented in the high risk AKRiS category. Both ARRS and AKRiS were significantly associated with ESKD ( p < 0.001), with ordinal increases in probability of ESKD with risk category (apart from very high risk AKRiS group). Harrell's C‐index for ARRS was 0.78 (95% CI: 0.705–0.862), and for AKRiS was 0.83 (95% CI: 0.753–0.896), without a significant increase with inclusion of ethnicity in the models. Brier scores were 0.131 for ARRS and 0.119 for AKRiS.

Conclusion

In a cohort of AoNZ AAV GN patients, both ARRS and AKRiS performed well in predicting the risk of ESKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney Failure, ChronicAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGlomerulonephritisHumansMaleNew ZealandRisk AssessmentFemaleRetrospective StudiesMiddle AgedRisk FactorsAgedPredictive Value of TestsAdultKidneyBiopsyImmunosuppressive AgentsPrognosis

Stichwörter der Autor:innen

New Zealandanti‐neutrophil cytoplasmic antibody‐associated vasculitischronic kidney failureglomerulonephritisrisk factors

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Renal Service, Auckland City Hospital, Auckland, New Zealand.

ORCID-Profile: Saiprasad Ravi

Zitieren

APA

Ravi, S., Ali, A., & Goh, T. L. (2026). Performance of the Anca Renal and Kidney Risk Scores in Predicting Renal Outcome in A New Zealand Cohort. Nephrology, 31(4). https://doi.org/10.1111/nep.70207

Vancouver

Ravi S, Ali A, Goh TL. Performance of the Anca Renal and Kidney Risk Scores in Predicting Renal Outcome in A New Zealand Cohort. Nephrology. 2026;31(4). doi:10.1111/nep.70207

BibTeX
@article{Ravi2026,
  author = {Ravi, Saiprasad and Ali, Alina and Goh, Tze Liang},
  title = {Performance of the Anca Renal and Kidney Risk Scores in Predicting Renal Outcome in A New Zealand Cohort},
  journal = {Nephrology},
  year = {2026},
  volume = {31},
  number = {4},
  doi = {10.1111/nep.70207}
}
Kostenlos starten →